Nutrivert: Postbiotics and the Promise of Non-Antibiotic Growth Promotion
You must be logged in to view presentation.
Sign In Register
According to some predictions, antibiotic-resistant bacteria will kill 10 million people and cause tremendous economic loss by 2050. A primary driver of selection for antibiotic-resistant bacteria is overuse of antibiotics in livestock, where the consumption of antibiotics by animals is forecast to rise to 200,000 tons annually by 2030. So far, non-antibiotic growth promoters have been unable to compete with antibiotics in reducing feed costs. Nutrivert’s non-antibiotic products exploit the previously unknown mechanism of action of antibiotic growth promoters, with results that so far have shown promise in testing in pigs and broilers.
[Content protected for Tier 3, Management Company Professionals, Financial Professional, Selection Committee, Investor members only]
Investments in private offerings are speculative, illiquid and involve a high degree of risk and those investors who cannot afford to lose their entire investment and who cannot hold an investment for an indeterminate period should not invest in such offerings. Past performance is not indicative of future results. Securities are offered through North Capital Private Securities, member FINRA/SIPC. All information provided herein should not be relied upon to make an investment decision and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Prospective investors are recommended to consult with a financial adviser, attorney, accountant, and any other professional that can help you understand and assess the risks associated with an investment opportunity.
